STEMREGEN News


News items related to STEMREGEN as issued by the Send2Press Newswire service on behalf of the noted news source.


Chris Spencer Announces ‘Real Husbands of Hollywood’ Returning for Sixth Season

HOLLYWOOD, Calif., Aug. 4, 2021 (SEND2PRESS NEWSWIRE) — Having just returned from Belize to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells, feature actor, comedian, writer and producer Chris Spencer is pleased to announce that everyone’s favorite husbands are coming back – the “Real Husbands of Hollywood” has been renewed for a sixth season by BET.

Kalyagen and Intelicure Announce Partnership to Distribute STEMREGEN in Canada

AUSTIN, Texas and VANCOUVER, B.C., June 4, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen® and Intelicure Health Inc. announced today that they have entered into an agreement to promote and distribute throughout Canada STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Next ‘The Stemregen Effect’ Commercial Featuring Chris Spencer to be Filmed in Belize

AUSTIN, Texas, May 13, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™ is pleased to announce that the next part of “The Stemregen Effect” digital media campaign will be filmed in Belize and feature actor, comedian, writer and producer Chris Spencer to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen Announces Release of ‘The Stemregen Effect’ Commercial with Three Former UCLA Players to Coincide with the Bruins Advancing to the Final Four

AUSTIN, Texas, April 3, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™ is pleased to announce the release of its “The Stemregen Effect” social media ad featuring former UCLA Bruins and NBA players Niguel Miguel, Marques Johnson and Mitchell Butler to promote STEMREGEN®, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous Stem Cell Mobilization (ESCM).

Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN┬« and Stem Cells for Advanced Heart Failure Patients

AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and Cell Therapy”), is pleased to announce the launch of a multicenter clinical trial, “The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination in Patient With Heart Failure,” to evaluate the use of stem cell therapies in patients suffering from heart failure.